Open Access
Open access
PLoS ONE, volume 15, issue 3, pages e0230301

Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing

Korostin Dmitriy 1
Naumov Vladimir 3
Kwon Dmitriy 4
Publication typeJournal Article
Publication date2020-03-16
Journal: PLoS ONE
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor3.7
ISSN19326203
Multidisciplinary
Abstract
The MGISEQ-2000 developed by MGI Tech Co. Ltd. (a subsidiary of the BGI Group) is a new competitor of such next-generation sequencing platforms as NovaSeq and HiSeq (Illumina). Its sequencing principle is based on the DNB and the cPAS technologies, which were also used in the previous version of the BGISEQ-500 device. However, the reagents for MGISEQ-2000 have been refined and the platform utilizes updated software. The cPAS method is an advanced technology based on the cPAL previously created by Complete Genomics. In this paper, the authors compare the results of the whole-genome sequencing of a DNA sample from a Russian female donor performed on MGISEQ-2000 and Illumina HiSeq 2500 (both PE150). Two platforms were compared in terms of sequencing quality, number of errors and performance. Additionally, we performed variant calling using four different software packages: Samtools mpileaup, Strelka2, Sentieon, and GATK. The accuracy of SNP detection was similar in the data generated by MGISEQ-2000 and HiSeq 2500, which was used as a reference. At the same time, a separate indel analysis of the overall error rate revealed similar FPR values and lower sensitivity. It may be concluded with confidence that the data generated by the analyzed sequencing systems is characterized by comparable magnitudes of error and that MGISEQ-2000 and HiSeq 2500 can be used interchangeably for similar tasks like whole genome sequencing.

Citations by journals

1
2
3
4
Frontiers in Genetics
Frontiers in Genetics, 4, 8.51%
Frontiers in Genetics
4 publications, 8.51%
Scientific Reports
Scientific Reports, 4, 8.51%
Scientific Reports
4 publications, 8.51%
International Journal of Legal Medicine
International Journal of Legal Medicine, 3, 6.38%
International Journal of Legal Medicine
3 publications, 6.38%
F1000Research
F1000Research, 2, 4.26%
F1000Research
2 publications, 4.26%
BMC Genomics
BMC Genomics, 2, 4.26%
BMC Genomics
2 publications, 4.26%
PeerJ
PeerJ, 1, 2.13%
PeerJ
1 publication, 2.13%
Cancers
Cancers, 1, 2.13%
Cancers
1 publication, 2.13%
Frontiers in Microbiology
Frontiers in Microbiology, 1, 2.13%
Frontiers in Microbiology
1 publication, 2.13%
Frontiers in Oncology
Frontiers in Oncology, 1, 2.13%
Frontiers in Oncology
1 publication, 2.13%
Frontiers in Plant Science
Frontiers in Plant Science, 1, 2.13%
Frontiers in Plant Science
1 publication, 2.13%
Frontiers in Medicine
Frontiers in Medicine, 1, 2.13%
Frontiers in Medicine
1 publication, 2.13%
Frontiers in Immunology
Frontiers in Immunology, 1, 2.13%
Frontiers in Immunology
1 publication, 2.13%
Life
Life, 1, 2.13%
Life
1 publication, 2.13%
Genes and Genomics, 1, 2.13%
Genes and Genomics
1 publication, 2.13%
Nature Computational Science
Nature Computational Science, 1, 2.13%
Nature Computational Science
1 publication, 2.13%
npj Regenerative Medicine
npj Regenerative Medicine, 1, 2.13%
npj Regenerative Medicine
1 publication, 2.13%
Cell Stem Cell
Cell Stem Cell, 1, 2.13%
Cell Stem Cell
1 publication, 2.13%
Fundamental Research
Fundamental Research, 1, 2.13%
Fundamental Research
1 publication, 2.13%
Small Methods
Small Methods, 1, 2.13%
Small Methods
1 publication, 2.13%
American Journal of Medical Genetics, Part A
American Journal of Medical Genetics, Part A, 1, 2.13%
American Journal of Medical Genetics, Part A
1 publication, 2.13%
Advanced Science
Advanced Science, 1, 2.13%
Advanced Science
1 publication, 2.13%
Drug Testing and Analysis
Drug Testing and Analysis, 1, 2.13%
Drug Testing and Analysis
1 publication, 2.13%
Aquaculture Reports
Aquaculture Reports, 1, 2.13%
Aquaculture Reports
1 publication, 2.13%
Critical Reviews in Clinical Laboratory Sciences
Critical Reviews in Clinical Laboratory Sciences, 1, 2.13%
Critical Reviews in Clinical Laboratory Sciences
1 publication, 2.13%
Breeding Science, 1, 2.13%
Breeding Science
1 publication, 2.13%
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika), 1, 2.13%
Epidemiology and Vaccinal Prevention (Epidemiologiya i Vaktsinoprofilaktika)
1 publication, 2.13%
Clinical Epigenetics
Clinical Epigenetics, 1, 2.13%
Clinical Epigenetics
1 publication, 2.13%
Plant Disease
Plant Disease, 1, 2.13%
Plant Disease
1 publication, 2.13%
1
2
3
4

Citations by publishers

2
4
6
8
10
12
Springer Nature
Springer Nature, 12, 25.53%
Springer Nature
12 publications, 25.53%
Frontiers Media S.A.
Frontiers Media S.A., 9, 19.15%
Frontiers Media S.A.
9 publications, 19.15%
Wiley
Wiley, 4, 8.51%
Wiley
4 publications, 8.51%
Elsevier
Elsevier, 3, 6.38%
Elsevier
3 publications, 6.38%
F1000 Research
F1000 Research, 2, 4.26%
F1000 Research
2 publications, 4.26%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 2, 4.26%
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 4.26%
PeerJ
PeerJ, 1, 2.13%
PeerJ
1 publication, 2.13%
The Korean Society of Genetics, 1, 2.13%
The Korean Society of Genetics
1 publication, 2.13%
Taylor & Francis
Taylor & Francis, 1, 2.13%
Taylor & Francis
1 publication, 2.13%
Japanese Society of Breeding, 1, 2.13%
Japanese Society of Breeding
1 publication, 2.13%
National Association of the Specialists in Control of Health Care-Associated Infections
National Association of the Specialists in Control of Health Care-Associated Infections, 1, 2.13%
National Association of the Specialists in Control of Health Care-Associated Infections
1 publication, 2.13%
American Phytopathological Society
American Phytopathological Society, 1, 2.13%
American Phytopathological Society
1 publication, 2.13%
2
4
6
8
10
12
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Korostin D. et al. Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing // PLoS ONE. 2020. Vol. 15. No. 3. p. e0230301.
GOST all authors (up to 50) Copy
Korostin D., Kulemin N., Naumov V., Belova V. A., Kwon D., Gorbachev A. Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing // PLoS ONE. 2020. Vol. 15. No. 3. p. e0230301.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1371/journal.pone.0230301
UR - https://doi.org/10.1371%2Fjournal.pone.0230301
TI - Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing
T2 - PLoS ONE
AU - Korostin, Dmitriy
AU - Kulemin, Nikolay
AU - Naumov, Vladimir
AU - Belova, Vera A.
AU - Kwon, Dmitriy
AU - Gorbachev, Alexey
PY - 2020
DA - 2020/03/16 00:00:00
PB - Public Library of Science (PLoS)
SP - e0230301
IS - 3
VL - 15
SN - 1932-6203
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Korostin,
author = {Dmitriy Korostin and Nikolay Kulemin and Vladimir Naumov and Vera A. Belova and Dmitriy Kwon and Alexey Gorbachev},
title = {Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing},
journal = {PLoS ONE},
year = {2020},
volume = {15},
publisher = {Public Library of Science (PLoS)},
month = {mar},
url = {https://doi.org/10.1371%2Fjournal.pone.0230301},
number = {3},
pages = {e0230301},
doi = {10.1371/journal.pone.0230301}
}
MLA
Cite this
MLA Copy
Korostin, Dmitriy, et al. “Comparative analysis of novel MGISEQ-2000 sequencing platform vs Illumina HiSeq 2500 for whole-genome sequencing.” PLoS ONE, vol. 15, no. 3, Mar. 2020, p. e0230301. https://doi.org/10.1371%2Fjournal.pone.0230301.
Found error?